Mélatonine
Food supplement declared in France, declaration No 2023-1-1710
Mélatonine (Orfito bioactive) is a food supplement declared in France. Status: retrait du marché annoncé pour le 20 December 2026. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- Orfito bioactive
- Food business operator placing the product on the market
- BioUltime
- Status
- Retrait du marché annoncé pour le 20 December 2026
- Form
- Comprimé
- Daily dose
- 1 comprimé
- Directions for use
- A avaler avec un verre d'eau 30 minutes avant le coucher
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Femmes enceintes
- Objectives stated by the manufacturer (these are not authorised claims)
- Sommeil
Declaration 211460, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retrait du marché annoncé pour le 20 December 2026, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Other active ingredients
| Name | Per day |
|---|---|
| Mélatonine | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Carbonate de magnésium | Magnésium | 250 mg | 300 mg |
Additives
E470b
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Déconseillé pour les personnes souffrants de maladie inflammatoires ou auto-immunes ; les femmes enceintes ou allaitantes ; les enfants et adolescents ; les personnes devant réaliser une activité nécessitant une vigilance soutenue et pouvant poser un problème de sécurité en cas de somnolence. Demander un avis médical pour les personnes épileptique, les personnes asthmatiques, les personnes souffrant de troubles de l'humeur, du comportement ou de la personnalité et les personnes suivants un traitement médicamenteux. Limiter la prise des compléments alimentaires à un usage ponctuel.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.
Brand : Orfito bioactive